Personal information

Websites & social links

LinkedIn

Countries

United Kingdom, Italy

Activities

Collapse all

Employment (1)

The University of Texas MD Anderson Cancer Center: Houston, Texas, US

2019-10 to 2021-03 | Graduate Research Student (Genitourinary Medical Oncology)
Employment
Source: Self-asserted source
Federica Mossa

Education and qualifications (3)

Barts and The London School of Medicine and Dentistry Blizard Institute: London, GB

2021-10 to present | PhD Student (Centre for Cell Biology and Cutaneous Research)
Education
Source: Self-asserted source
Federica Mossa

Università Vita-Salute San Raffaele Facoltà di Medicina e Chirurgia: Milano, Lombardia, IT

2018-10 to 2021-03 | MSc in Biotechnology and Medical Biology
Education
Source: Self-asserted source
Federica Mossa

Università Vita-Salute San Raffaele Facoltà di Medicina e Chirurgia: Milano, Lombardia, IT

2015-10 to 2018-11 | BSc in Medical and Pharmaceutical Biotechnologies
Education
Source: Self-asserted source
Federica Mossa

Works (6)

The paradox of senescent-marker positive cancer cells: challenges and opportunities

npj Aging
2024-09-14 | Journal article
DOI: 10.1038/s41514-024-00168-y
Contributors: Emily A. O’Sullivan; Ryan Wallis; Federica Mossa; Cleo L. Bishop
Source: check_circle
Crossref

Data from Subtype and Site Specific–Induced Metabolic Vulnerabilities in Prostate Cancer

2023-04-03 | Preprint
DOI: 10.1158/1541-7786.c.6545448.v1
Contributors: Federica Mossa; Daniele Robesti; Ramachandran Sumankalai; Eva Corey; Mark Titus; Yuqi Kang; Jianhua Zhang; Alberto Briganti; Francesco Montorsi; Christopher P. Vellano et al.
Source: check_circle
Crossref

Data from Subtype and Site Specific–Induced Metabolic Vulnerabilities in Prostate Cancer

2023-04-03 | Preprint
DOI: 10.1158/1541-7786.c.6545448
Contributors: Federica Mossa; Daniele Robesti; Ramachandran Sumankalai; Eva Corey; Mark Titus; Yuqi Kang; Jianhua Zhang; Alberto Briganti; Francesco Montorsi; Christopher P. Vellano et al.
Source: check_circle
Crossref

Supplementary Figures 1-4 from Subtype and Site Specific–Induced Metabolic Vulnerabilities in Prostate Cancer

2023-04-03 | Preprint
DOI: 10.1158/1541-7786.22527513
Contributors: Federica Mossa; Daniele Robesti; Ramachandran Sumankalai; Eva Corey; Mark Titus; Yuqi Kang; Jianhua Zhang; Alberto Briganti; Francesco Montorsi; Christopher P. Vellano et al.
Source: check_circle
Crossref

Supplementary Figures 1-4 from Subtype and Site Specific–Induced Metabolic Vulnerabilities in Prostate Cancer

2023-04-03 | Preprint
DOI: 10.1158/1541-7786.22527513.v1
Contributors: Federica Mossa; Daniele Robesti; Ramachandran Sumankalai; Eva Corey; Mark Titus; Yuqi Kang; Jianhua Zhang; Alberto Briganti; Francesco Montorsi; Christopher P. Vellano et al.
Source: check_circle
Crossref

Subtype and Site Specific–Induced Metabolic Vulnerabilities in Prostate Cancer

Molecular Cancer Research
2023-01-03 | Journal article
DOI: 10.1158/1541-7786.MCR-22-0250
Contributors: Federica Mossa; Daniele Robesti; Ramachandran Sumankalai; Eva Corey; Mark Titus; Yuqi Kang; Jianhua Zhang; Alberto Briganti; Francesco Montorsi; Christopher P. Vellano et al.
Source: check_circle
Crossref
How many people are using ORCID?